Cutler Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-300
| Closed | -$10.6K | – | 4404 |
|
|
2023
Q1 | $7K | Sell |
300
-700
| -70% | -$15.3K | ﹤0.01% | 2590 |
|
|
2022
Q4 | $21K | Sell |
1,000
-2,482
| -71% | -$53K | ﹤0.01% | 2201 |
|
|
2022
Q3 | $62K | Buy |
+3,482
| New | +$45.7K | ﹤0.01% | 1753 |
|
|
2022
Q1 | – | Sell |
-600
| Closed | -$8.87K | – | 6319 |
|
|
2021
Q4 | $10K | Buy |
+600
| New | +$9.83K | ﹤0.01% | 3744 |
|
|
2020
Q4 | – | Sell |
-200
| Closed | -$1K | – | 5691 |
|
|
2020
Q3 | $1K | Buy |
+200
| New | +$954 | ﹤0.01% | 4527 |
|
|
2019
Q4 | – | Sell |
-1,800
| Closed | -$6.43K | – | 4807 |
|
|
2019
Q3 | $2K | Hold |
1,800
| – | – | ﹤0.01% | 3598 |
|
|
2019
Q2 | $2K | Hold |
1,800
| – | – | ﹤0.01% | 3704 |
|
|
2019
Q1 | $2K | Sell |
1,800
-1,153
| -39% | -$1.61K | ﹤0.01% | 3517 |
|
|
2018
Q4 | $3K | Hold |
2,953
| – | – | ﹤0.01% | 3268 |
|
|
2018
Q3 | $6K | Hold |
2,953
| – | – | ﹤0.01% | 2986 |
|
|
2018
Q2 | $8K | Hold |
2,953
| – | – | ﹤0.01% | 2851 |
|
|
2018
Q1 | $8K | Sell |
2,953
-2,500
| -46% | -$7.25K | ﹤0.01% | 2992 |
|
|
2017
Q4 | $17K | Sell |
5,453
-35
| -0.6% | -$98 | ﹤0.01% | 2724 |
|
|
2017
Q3 | $15K | Buy |
5,488
+600
| +12% | +$1.62K | ﹤0.01% | 3443 |
|
|
2017
Q2 | $12K | Sell |
4,888
-30,265
| -86% | -$82.4K | ﹤0.01% | 4008 |
|
|
2017
Q1 | $128K | Buy |
35,153
+3,757
| +12% | +$15.9K | 0.01% | 1523 |
|
|
2016
Q4 | $151K | Buy |
31,396
+3,813
| +14% | +$113K | 0.01% | 1546 |
|
|
2016
Q3 | $1.27M | Buy |
27,583
+20,095
| +268% | +$1.13M | 0.06% | 246 |
|
|
2016
Q2 | $382K | Buy |
7,488
+5,251
| +235% | +$261K | 0.02% | 730 |
|
|
2016
Q1 | $94K | Sell |
2,237
-879
| -28% | -$44.8K | 0.01% | 1679 |
|
|
2015
Q4 | $244K | Buy |
+3,116
| New | +$180K | 0.01% | 1032 |
|
Cutler Group's ISEE Position: Q2 2023 in Review
Cutler Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 300 shares — an estimated $10.6K sold.
Cutler Group first reported a position in ISEE in Q4 2015 and held it in 21 quarters. The position peaked at $1.27M in Q3 2016. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Cutler Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Cutler Group sold 300 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $10.6K.
- Cutler Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 21 quarters.
- Cutler Group's IVERIC bio, Inc. Common Stock position peaked at $1.27M in Q3 2016.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.